Comments on H.R. 6522
B-197871: Published: Mar 18, 1980. Publicly Released: Mar 18, 1980.
Additional Materials:
- Full Report:
Contact:
H.R. 6522 would amend the Public Health Service Act and revise and extend the authorities under the Act relating to national research institutes. GAO recommended changes to H.R. 6522 as follows. (1) Because of the importance of the Division of Research Resources (DRR) of the National Institutes of Health (NIH) from both a programmatic and a budgetary standpoint, DRR should be acknowledged as an operating entity of NIH, its functions formally stated, and its appropriation amounts designated. (2) Language in the legislation should be altered to provide for mandatory advisory council review of grants and contracts on the basis of total costs of $70,000 rather than direct costs of $50,000. (3) Separate provisions for the limitation and authorization of cancer control programs and cancer-related support programs are unnecessary since they are covered by existing provisions of the Act. (4) Certain outdated language referring to the transfer of appropriations should be changed as specified since DRR operates general support programs which benefit all NIH research institutes. (5) Provisions in H.R. 6522 for an evaluation of the National Research Service Awards program to be submitted by January 1, 1982, are questionable since the bill also provides for the Secretary of Health, Education, and Welfare to arrange for a continuing study of various matters pertinent to the program; furthermore, the reporting date of January 1, 1982, would be too early to assess the effects of certain changes required by the bill.
Mar 1, 2021
-
Medicare Part B:
Payments and Use for Selected New, High-Cost DrugsGAO-21-252: Published: Mar 1, 2021. Publicly Released: Mar 1, 2021.
Feb 24, 2021
-
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021. -
Health Care Funding:
Federal Obligations to and Funds Received by Certain Organizations Involved in Health-Related Services, 2016 through 2018GAO-21-188R: Published: Dec 21, 2020. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here